 The market capitalization of AIM stocks was £99.6bn as of 14 April 2023, up 5.0% since our update on 30 March 2023. Among the top YTD winners, there were Celadon Pharmaceuticals (up 236.6%), Vast Resources (+229% YTD, Mkt cap of £15.4m), Kodal Mineral (+194.4%), Clontarf Energy (+164%), Inspecs Group (+156%). Among the bottom movers, apart from companies canceling their admission to AIM, remain Applied Graphene Materials (-88%, MktCap £0.6mn), Midatech Pharma (-88.6%), Morses Club (-82%, MktCap £0.3mn), Advanced Oncotherapy (-81%). Over the last two weeks, the AIM market performance improved bringing YTD gains to 13.1% in Financials, 10.5% in Basic Materials, and 10.1% in Consumer Non-Cyclicals sectors. The biggest losses remain in Academic and Educational Services and Real Estate.  Improving market performance affected the gains of our picks. We have chosen two gold and one platinum stock in our previous screening. Inspired was down 9.8% since our pricing on 29 March. Strix Group was up 12.2% on the £3.25 dividend announcement and hVIVO was up 10.3% on positive results from influenza human challenge study between 29 March 2023 and 14 April 2023. Sigmaroc added 3.8% for the period.  We continue to choose companies with sustainable business models. The market performance improved after the banking risks weakened. We select companies with projected revenue growth above 20% and sustainable business model. Our picks list includes Bango, Arrow Exploration, Elixirr International, and Equals Group PLC. Our choice is based on projected sales growth, comparable multiples, and recent performance. Companies are subject to AIM stock risks such as financial underperformance or stock dilutions in the future. We believe our top picks have an acceptable risk-return trade-off due to a sustainable product range or business model.